---
title: "Vaccine Effectiveness Methods"
subtitle: "Statistical methods for estimating vaccine protection from observational data"
page-layout: article
title-block-banner: "#8e44ad"
title-block-banner-color: white
---

```{=html}
<style>
.highlight-card {
  border-left: 4px solid #8e44ad;
  background: linear-gradient(135deg, #f8f9fa 0%, #f3e5f5 100%);
  padding: 1.5rem;
  margin: 1.5rem 0;
  border-radius: 0 8px 8px 0;
}

.project-card {
  background: white;
  border: 1px solid #dee2e6;
  border-radius: 12px;
  padding: 1.5rem;
  margin: 1rem 0;
  box-shadow: 0 2px 8px rgba(0,0,0,0.08);
  transition: transform 0.2s ease, box-shadow 0.2s ease;
}

.project-card:hover {
  transform: translateY(-2px);
  box-shadow: 0 4px 16px rgba(0,0,0,0.12);
}

.project-card h3 {
  color: #2c3e50;
  margin-bottom: 0.75rem;
  font-size: 1.25rem;
}

.pub-item {
  background: #f8f9fa;
  padding: 1rem 1.25rem;
  margin: 0.75rem 0;
  border-radius: 8px;
  border-left: 3px solid #8e44ad;
}

.pub-item:hover {
  background: #e9ecef;
}

.section-header {
  border-bottom: 2px solid #8e44ad;
  padding-bottom: 0.5rem;
  margin-top: 2.5rem;
  margin-bottom: 1.5rem;
}

.featured-image {
  border-radius: 12px;
  box-shadow: 0 4px 20px rgba(0,0,0,0.15);
  margin: 2rem 0;
}

.back-link {
  display: inline-flex;
  align-items: center;
  gap: 0.5rem;
  color: #6c757d;
  text-decoration: none;
  font-weight: 500;
  margin-top: 2rem;
  padding: 0.5rem 1rem;
  border-radius: 6px;
  transition: all 0.2s ease;
}

.back-link:hover {
  background: #f8f9fa;
  color: #2c3e50;
}

.method-grid {
  display: grid;
  grid-template-columns: repeat(auto-fit, minmax(250px, 1fr));
  gap: 1rem;
  margin: 1.5rem 0;
}

.method-item {
  background: #f3e5f5;
  padding: 1.25rem;
  border-radius: 10px;
  border: 1px solid #e1bee7;
}

.method-item h4 {
  color: #8e44ad;
  margin: 0 0 0.5rem 0;
  font-size: 1rem;
}

.method-item p {
  margin: 0;
  font-size: 0.9rem;
  color: #555;
}

.vaccine-tags {
  display: flex;
  flex-wrap: wrap;
  gap: 0.5rem;
  margin-top: 1rem;
}

.vaccine-tag {
  background: #8e44ad;
  color: white;
  padding: 0.35rem 0.75rem;
  border-radius: 20px;
  font-size: 0.85rem;
  font-weight: 500;
}
</style>
```

::: {.highlight-card}
**Focus:** Developing and evaluating statistical methods that provide reliable vaccine effectiveness estimates while accounting for biases in observational study designs.
:::

![](../images/placeholder_ve.jpg){.featured-image fig-align="center" width="100%"}

## WAVE Project {.section-header}

::: {.project-card}
### Evaluation of Waning Vaccine Effectiveness

The COVID-19 pandemic highlighted the critical need for robust methods to assess how vaccine protection changes over time. The **WAVE** project addresses this gap through rigorous methodological development.

::: {.method-grid}
::: {.method-item}
#### Method Development
Rigorously compare approaches for assessing waning vaccine-induced protection
:::

::: {.method-item}
#### True vs Perceived Waning
Distinguish actual immunity decline from changes in pathogen or population
:::

::: {.method-item}
#### Individual Determinants
Identify how characteristics influence rate of protection decline
:::

::: {.method-item}
#### Multi-Disease Application
Methods applicable across multiple vaccine types
:::
:::

::: {.vaccine-tags}
[Pertussis]{.vaccine-tag}
[Influenza]{.vaccine-tag}
[COVID-19]{.vaccine-tag}
[Rotavirus]{.vaccine-tag}
:::
:::

## Influenza Vaccine Effectiveness {.section-header}

::: {.project-card}
### Bias in Observational Studies

I developed dynamic transmission models to evaluate sources of bias in observational VE studies, particularly the **test-negative design**. This work identified conditions under which test-negative studies may over- or underestimate true VE, providing guidance for study design and interpretation.
:::

::: {.project-card}
### Transmission Blocking

Using **maximum likelihood estimation**, I developed methods to estimate VE against both:

- **Susceptibility** to infection
- **Transmission** to others

These methods use household surveillance data to separately estimate these two components of vaccine protection.
:::

::: {.project-card}
### Repeat Vaccination Effects

Annual influenza vaccination raises questions about how prior vaccination affects current season protection. Using individual-based stochastic models (**morevac**), I investigated optimal vaccination strategies in children, accounting for complex exposure histories and antigenic dynamics.
:::

## Key Publications {.section-header}

::: {.pub-item}
**Ainslie, K. E. C.**, *et al*. A Dynamic Model for Evaluation of the Bias of Influenza Vaccine Effectiveness Estimates. *Am J Epidemiol.* 2018. [Read paper →](https://doi.org/10.1093/aje/kwy240)
:::

::: {.pub-item}
**Ainslie, K. E. C.**, *et al*. Challenges in estimating influenza vaccine effectiveness. *Expert Rev Vaccines.* 2019. [Read paper →](https://doi.org/10.1080/14760584.2019.1622419)
:::

::: {.pub-item}
**Ainslie, K. E. C.**, *et al*. Maximum likelihood estimation of influenza vaccine effectiveness against transmission. *Stat Med.* 2017. [Read paper →](https://doi.org/10.1002/sim.7558)
:::

::: {.pub-item}
**Ainslie, K. E. C.** and Riley, S. Is annual vaccination best? A modelling study of influenza vaccination strategies in children. *Vaccine* 2022. [Read paper →](https://doi.org/10.1016/j.vaccine.2022.03.065)
:::

::: {.pub-item}
Haber, M., *et al*. Comparing statistical methods for detecting and estimating waning efficacy of rotavirus vaccines in developing countries. *Hum Vaccin Immunother.* 2021. [Read paper →](https://pubmed.ncbi.nlm.nih.gov/34613877/)
:::

::: {.pub-item}
Tsang, T. K., *et al*. Prior infections and effectiveness of SARS-CoV-2 vaccine in test-negative studies. *Am J Epidemiol.* 2024. [Read paper →](https://doi.org/10.1093/aje/kwae142)
:::

## Related Software {.section-header}

::: {.btn-group}
[morevac](https://github.com/kylieainslie/morevac){.btn .btn-primary .btn-sm style="background-color: #8e44ad; border-color: #8e44ad;"}
:::

<a href="../research.html" class="back-link">← Back to Research</a>
